title: Burden of Clostridium difficile on the healthcare system.
abstract: There are few high-quality studies of the costs of Clostridium difficile infection (CDI), and the majority of studies focus on the costs of CDI in acute-care facilities. Analysis of the best available data, from 2008, indicates that CDI may have resulted in $4.8 billion in excess costs in US acute-care facilities. Other areas of CDI-attributable excess costs that need to be investigated are costs of increased discharges to long-term care facilities, of CDI with onset in long-term care facilities, of recurrent CDI, and of additional adverse events caused by CDI.
authors: Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA. edubberk@dom.wustl.edu
authors: Erik R
authors: ER
authors: Dubberke
authors: Margaret A
authors: MA
authors: Olsen
mesh_terms: D016360:Clostridioides difficile / Q000472:pathogenicity*; D003015:Clostridium Infections / Q000191:economics* / Q000453:epidemiology / Q000382:microbiology; D017281:Cost of Illness; D003695:Delivery of Health Care / Q000191:economics*; D019468:Disease Management; D006760:Hospitalization / Q000191:economics; D006801:Humans; D008134:Long-Term Care / Q000191:economics; D010351:Patient Discharge / Q000191:economics; D012008:Recurrence; D013997:Time Factors; D014481:United States / Q000453:epidemiology